Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
about
Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patientsOral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS.Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy.In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus.
P2860
Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Pharmacokinetics and safety of ...... eiving concomitant zidovudine.
@en
Pharmacokinetics and safety of ...... eiving concomitant zidovudine.
@nl
type
label
Pharmacokinetics and safety of ...... eiving concomitant zidovudine.
@en
Pharmacokinetics and safety of ...... eiving concomitant zidovudine.
@nl
prefLabel
Pharmacokinetics and safety of ...... eiving concomitant zidovudine.
@en
Pharmacokinetics and safety of ...... eiving concomitant zidovudine.
@nl
P2093
P2860
P1476
Pharmacokinetics and safety of ...... eiving concomitant zidovudine.
@en
P2093
P2860
P304
P407
P577
1997-08-01T00:00:00Z